BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Viyash Scientific Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
512529
ISIN Demat
INE807F01027
Book Value (Rs)
70.4015935
NSE Symbol
VIYASH
Divident Yield %
0
Market Cap
(Rs In Cr.)
11,581
P/E (TTM)
135.7
EPS (TTM)
1.94
Face Value
(Rs)
2
Back
Viyash Scientific consolidated net profit rises 459.12% in the March 2026 quarter
20-May-26   Hrs IST

Net profit of Viyash Scientific rose 459.12% to Rs 52.11 crore in the quarter ended March 2026 as against Rs 9.32 crore during the previous quarter ended March 2025. Sales rose 129.02% to Rs 919.96 crore in the quarter ended March 2026 as against Rs 401.70 crore during the previous quarter ended March 2025.

For the full year,net profit rose 663.48% to Rs 177.28 crore in the year ended March 2026 as against Rs 23.22 crore during the previous year ended March 2025. Sales rose 13.75% to Rs 3420.31 crore in the year ended March 2026 as against Rs 3006.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales919.96401.70 129 3420.313006.84 14
OPM %20.0311.51 -19.0812.87 -
PBDT185.6532.77 467 626.87333.45 88
PBT125.2416.65 652 393.2394.74 315
NP52.119.32 459 177.2823.22 663

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)